Atherosclerosis is characterized by narrowing and hardening of blood vessels. In this condition, fatty substances like for the vital organs like heart and brain. The risk related with atherosclerosis contains severe cardiovascular diseases and brain diseases. Inclusively, these conditions are more frequent for cardiovascular disease (CVD), containing transitory ischemia, angina pectoris, and coronary heart disease. Other risks of atherosclerosis contain peripheral vascular disease, renal disease, and carotid vascular disease.
Get Free PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
The growing number of pipeline studies and the increasing involvement of key players in developing treatment options for atherosclerosis are expected to drive the growth of the global atherosclerosis treatment drug market. For Example, Bayer and Janssen, LP joined forces in November 13, 2018, and began clinical studies of rivaroxaban and acetylsalicylic acid to build insights into treatment methods and to study the effects of rivaroxaban (Xarelto) in combination with acetylsalicylic acid (xatoa) prescribed to patients with atherosclerosis. The study is expected to complete in August 2021.
Furthermore, technological advances in the treatment of atherosclerosis are expected to drive the growth of the atherosclerosis treatment medicine market. For example, Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center developed Nano polymer therapy in May 2017, a new remedy for the treatment of atherosclerosis. It prevents heart failure with a new biomedical polymer (E-selectin-targeting polymer) that reduces arterial plaque and inflammation in the cardiovascular system. The e-selection-targeting polymer helps reducing existing plaque and prevents further formation of plaque. It also stops stroke, myocardial infection, ischemia, and arterial thrombosis.
Though, the side effects linked with atherosclerosis medicines and limited efficacy of the medicines is expected to hinder the growth of the atherosclerosis market. For example, The Lancet, accompanied by Rory Collins, serves evidence on statin therapy and methodological restraints, in November 2016. According to the data, statins are linked with an surged incidence of diabetes and haemorrhagic stroke. Due to statins the risk og type 2 diabetes increases in dose-dependent mode.
Request PDF Brochure with Latest Insights @
Regionally, Due to the increasing incidence of atherosclerotic conditions in the population of North America, it is expected to gain significant market share in the forecast period. For example, as per data provided by the U.S. CDCP and WHO in November 2016, there were over 15.5 million Americans with coronary vascular disease, and one American is expected to experience a myocardial infection every 42 seconds.
In addition, The expansion of key players in the region is expected to lead to significant growth in the Asia-Pacific market. For example, GSK opens its new regional headquarters for Asia in Singapore. GSK aims to support the pharmaceutical, vaccine and consumer healthcare businesses in a number of regions across Asia Pacific.
Key players performing in the Global Atherosclerosis Treatment Drugs Market are Cardium Therapeutics, The Medicine Company, Bayer AG, Johnson and Johnson, Sanofi, Novartis AG, Anthera Pharmaceuticals, Isis Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., and GlaxoSmithKline plc. Merck & Co., Inc.
Reasons to Buy this Atherosclerosis Treatment Drugs Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Atherosclerosis Treatment Drugs market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Atherosclerosis Treatment Drugs market
➡Leading company profiles reveal details of key Atherosclerosis Treatment Drugs market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Atherosclerosis Treatment Drugs market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
𝐋𝐈𝐌𝐈𝐓𝐄𝐃 𝐓𝐈𝐌𝐄 𝐎𝐅𝐅𝐄𝐑 – 𝐇𝐮𝐫𝐫𝐲 𝐔𝐩 !!!
𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎%
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/2430
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Atherosclerosis Treatment Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Atherosclerosis Treatment Drugs Industry Impact
Chapter 2 Global Atherosclerosis Treatment Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Atherosclerosis Treatment Drugs (Volume and Value) by Type
2.3 Global Atherosclerosis Treatment Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Atherosclerosis Treatment Drugs Sales, Consumption, Export, Import by Regions
Chapter 5 North America Atherosclerosis Treatment Drugs Market Analysis
Chapter 6 East Asia Atherosclerosis Treatment Drugs Market Analysis
Chapter 7 Europe Atherosclerosis Treatment Drugs Market Analysis
Chapter 8 South Asia Atherosclerosis Treatment Drugs Market Analysis
Chapter 9 Southeast Asia Atherosclerosis Treatment Drugs Market Analysis
Chapter 10 Middle East Atherosclerosis Treatment Drugs Market Analysis
Chapter 11 Africa Atherosclerosis Treatment Drugs Market Analysis
Chapter 12 Oceania Atherosclerosis Treatment Drugs Market Analysis
Chapter 13 South America Atherosclerosis Treatment Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Atherosclerosis Treatment Drugs Business
Chapter 15 Global Atherosclerosis Treatment Drugs Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027